Loading chat...
AL HB754
Bill
Status
4/26/2012
Primary Sponsor
Gregory Wren
Click for details
AI Summary
HB754 Summary
-
Allows certified registered nurse practitioners (CRNPs) and certified nurse midwives (CNMs) with collaborative practice agreements to prescribe Schedule III, IV, and V controlled substances after obtaining a Qualified Alabama Controlled Substances Registration Certificate (QACSC).
-
Requires applicants to complete Board of Medical Examiners-approved coursework in advanced pharmacology, maintain 12 months of active clinical practice under a collaborative agreement, and obtain a valid DEA registration number.
-
Designates the Board of Medical Examiners as the certifying body to issue QACSC certificates, establish formularies, adopt regulations, set fees not to exceed $1,000 per violation, and conduct disciplinary proceedings.
-
Establishes grounds for denial or disciplinary action including fraud, drug-related convictions, unsafe prescribing practices, substance abuse, and violations of article requirements; prohibits self-prescribing and stock supply purchases.
-
Allows judicial review of board decisions in Montgomery County Circuit Court with restrictions on stays of suspension or revocation orders unless board action was without statutory authority, arbitrary, capricious, or a gross abuse of discretion.
Legislative Description
Nurses, certified registered nurse practitioners and certified nurse midwives, authorized to prescribe certain controlled substances, Secs. 20-2-214, 20-2-217 am'd; Secs. 20-2-250 to 20-2-259, inclusive, added
Nurses and Nursing
Last Action
Read for the first time and referred to the House of Representatives committee on Health
4/26/2012